HALO logo
halo search icon
Cytek Biosciences, Inc.

US$3.96

Price Change Indicator
0.19 (5.04%)
Cytek Biosciences, Inc.
CTKB · NAS

Cytek Biosciences, Inc.

Start Trading CTKB for Free

US$3.96

Price Arrow0.19 (5.04%)
21/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusConsensus CheapEMA 125 BreakdownHALO AllHALO Balance Sheet
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Cytek Biosciences, Inc. Overview

CTKB Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Strong

About CTKB

icon

Website

Cytek Biosciences, Inc.

icon

Telephone

1.877.922.9835

icon

Address

47215 Lakeview Boulevard, Fremont, CA 94538

Description

Cytek Biosciences, Inc. is a life sciences technology company, which engages in the provision of cell analysis tools by leveraging novel technical approaches. Its products include Cytek Aurora CS, Cytek Aurora, Cytek Northern Lights, and Cytek NL-CLC. The company was founded by Wenbin Jiang and Ming Yan in 1992 and is headquartered in Fremont, CA.

CTKB Price Chart

Key Stats

Market Cap

US$486.87M

PE

601.60

EV/EBITDA

11.6

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 2.37 - 6.18

Trade Value (12mth)

US$1,111,518.00

1 week

10.72%

1 month

-18.92%

YTD

-23.37%

1 year

53.88%

All time high

28.70

Key Fundamentals

EPS 3 yr Growth

-2813.00%

EBITDA Margin

-14.10%

Operating Cashflow

-$5m

Free Cash Flow Return

-1.20%

ROIC

-17.10%

Interest Coverage

-59.90

Quick Ratio

4.40

Other Data

Shares Outstanding (Fully Diluted)

129m

HALO Sector

Healthcare

Next Company Report Date

04-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

CTKB Announcements

Latest Announcements

DateAnnouncements
08 May 26
08 May 26
08 May 26
08 May 26
27 February 26

CTKB Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-0.09-0.05-0.52locklocklock
EPS (Fully Diluted)
 $locklocklocklock-0.09-0.05-0.52locklocklock
Growth
 %locklocklocklock-567.748.7-1,029.9locklocklock
PE
 Xlocklocklocklock49052.2601.6locklocklock
EV/EBITDA
 Xlocklocklocklock229.919.411.6locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Cytek Biosciences, Inc. (CTKB:NAS)?
Halo FAQ
The current share price of Cytek Biosciences, Inc. (CTKB:NAS) is USD$3.96.
What is the 52-week high share price for Cytek Biosciences, Inc. (CTKB:NAS)?
Halo FAQ
The 52-week high share price for Cytek Biosciences, Inc. (CTKB:NAS) is USD$6.18.
What is the 52-week low share price for Cytek Biosciences, Inc. (CTKB:NAS)?
Halo FAQ
The 52-week low share price for Cytek Biosciences, Inc. (CTKB:NAS) is USD$2.37.
What is the dividend yield for Cytek Biosciences, Inc. (CTKB:NAS)?
Halo FAQ
Cytek Biosciences, Inc. (CTKB:NAS) does not pay a dividend.
What was Cytek Biosciences, Inc. (CTKB:NAS) last dividend payment?
Halo FAQ
Cytek Biosciences, Inc. (CTKB:NAS) does not pay a dividend.
What is the franking level for Cytek Biosciences, Inc. (CTKB:NAS)?
Halo FAQ
Cytek Biosciences, Inc. (CTKB:NAS) has a franking level of 0.00%.
In which sector is Cytek Biosciences, Inc. (CTKB:NAS) classified?
Halo FAQ
Cytek Biosciences, Inc. (CTKB:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Cytek Biosciences, Inc. (CTKB:NAS)?
Halo FAQ
The current P/E ratio for Cytek Biosciences, Inc. (CTKB:NAS) is 601.60.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial